Patent ID: 9364466
Filing Date: 2016-06-14
CPC Classification: A61K,A61P,C07D

Claim Text:
1. A method for inhibiting JAK1, JAK2, JAK3, or TYK2 in a subject, comprising administering to a subject in need thereof a therapeutically effective amount of a compound having the structure of formula (I), a pharmaceutically acceptable salt thereof, a prodrug thereof, or a hydrate thereof, wherein: A represents CR and B represents N; R and R′ independently represent H, (C R″ represents H, halogen or —NR R R R R R R R R p represents an integer of 1 or 2; q represents an integer of 0, 1, 2 or 3; r represents an integer of 0, 1, 2, 3 or 4; and s represents an integer of 0, 1 or 2; R R R′″ represents H or (C